Biologics and global burden of asthma: A worldwide portrait and a call for action

Biologics for severe asthma can significantly impact on the burden of disease and also have the potential to reduce asthma mortality. By reviewing the literature and contacting the pharmaceutical companies, the present paper aims at providing a worldwide snapshot of biologic drugs availability, rela...

Full description

Saved in:

Bibliographic Details
Published in:	The World Allergy Organization journal Vol. 14; no. 2; p. 100502
Main Authors:	Caminati, M., Morais-Almeida, M., Bleecker, E., Ansotegui, I., Canonica, G.W., Bovo, C., Senna, G.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.02.2021 Elsevier BV World Allergy Organization Elsevier
Subjects:	Allergies Asthma Asthma costs Asthma mortality Biological products Biologics Chronic obstructive pulmonary disease Drugs Health care access Health care expenditures High income Low income groups Monoclonal antibodies Morbidity Mortality Pharmaceutical industry Risk factors Severe asthma Severe asthma prevalence Socioeconomic factors Steroids South Korea United States > US Asia Japan Europe Africa Israel North America Russia Asthma costs Severe asthma Severe asthma prevalence Asthma mortality Biologics
ISSN:	1939-4551, 1939-4551
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!